SILO PHARMA - Trademark Details
Status: 661 - Response After Non-Final Action - Entered
Serial Number
90249449
Word Mark
SILO PHARMA
Status
661 - Response After Non-Final Action - Entered
Status Date
2022-02-01
Filing Date
2020-10-12
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
L90
Employee Name
LOBO, DEBORAH E
Statements
Disclaimer with Predetermined Text
"PHARMA"
Goods and Services
Biological research; Laboratory research services relating to pharmaceuticals; Medical research; Pharmaceutical drug development services; Pharmaceutical research services; Product research and development
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-11-29
Primary Code
042
First Use Anywhere Date
2020-01-15
First Use In Commerce Date
2020-01-15
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Paul Garrity
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2020-10-15 | NEW APPLICATION ENTERED IN TRAM |
2020-11-29 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2021-03-10 | ASSIGNED TO EXAMINER |
2021-03-16 | ASSIGNED TO EXAMINER |
2021-07-22 | ASSIGNED TO EXAMINER |
2021-07-30 | NON-FINAL ACTION WRITTEN |
2021-07-30 | NON-FINAL ACTION E-MAILED |
2021-07-30 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2022-01-31 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2022-01-31 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2022-02-01 | TEAS/EMAIL CORRESPONDENCE ENTERED |